| Trial ID: | L0902 |
| Source ID: | NCT02117700
|
| Associated Drug: |
N-acetyl cysteine
|
| Title: |
Effect of N-acetyl Cysteine on Non Alcoholic Fatty Liver Disease in Obese Children
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Obesity;Nonalcoholic Fatty Liver Disease;Cardiovascular Disease
|
| Interventions: |
Dietary Supplement: N-acetyl cysteine 600 mg once/day;Dietary Supplement: N-acetyl cysteine 600mg twice/day;Other: Placebo twice/day
|
| Outcome Measures: |
Change in liver fat (MRI) and ALT levels from baseline and at 16 weeksnan
|
| Sponsor/Collaborators: |
Nemours Children's Clinic
|
| Gender: |
All
|
| Age: |
7 Years18 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
14
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
16/04/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02117700
|
